ASMA BRONKIAL EKSASERBASI RINGAN-SEDANG PADA PASIEN PEREMPUAN USIA 46 TAHUN

Authors

  • Puspa Rosfadilla
  • Ayu Permata Sari

DOI:

https://doi.org/10.29103/averrous.v8i1.7115

Keywords:

asma bronkial, kortikosteroid, long acting bronchodilator (LABA)

Abstract

Asma bronkial adalah gangguan inflamasi kronik pada saluran nafas. Asma bertanggung jawab atas 21,6 juta DALYs (Disability-Adjusted Life Year) pada tahun 2019, yang merupakan 20,8% dari total DALYs dari penyakit pernapasan kronis. Berdasarkan hasil Survey Kesehatan Rumah Tangga (SKRT) tahun 2017, asma merupakan penyebab kematian (mortalitas) keempat di Indonesia atau sebesar 5,6%. Laporan kasus ini didapatkan dari data primer melalui anamnesis, pemeriksaan fisik dan pemeriksaan penunjang. Pasien mengeluh sesak nafas ketika malam hari dengan nafas berbunyi. Sesak bersifat terus-menerus dan memberat. Sebelumnya sesak sudah pernah muncul ketika terhirup asap dan cuaca dingin. Pemeriksaan laboratorium darah didapatkan peningkatan nilai kadar eosinofil. Pada pasien ini dilakukan penanganan berupa penatalaksanaan non farmakologi dan farmakologi berupa nebulisasi kortikosteroid dengan long acting bronchodilator (LABA).

Author Biography

Puspa Rosfadilla

Fakultas Kedokteran Universitas Malikussaleh

References

American Academy of Allergy Asthma & Immunology. Asthma & Immunology. 2013.

Fitri K, Kartikasari D. Gambaran Tingkat Kontrol Asma Pada Pasien Asma: Literature Review. Semin Nas Kesehat. 2021;71:1016-22.

Global Health Metrics. Asthma ” Level 3 cause. Lancet. 2020;396:108-9.

Welsh ET. Global burden of asthma decreased from 1990 to 2019 [Internet]. Healio pulmonolgy. 2021. Available from: https://www.healio.com/news/pulmonology/20211110/global-burden-of-asthma-decreased-from-1990-to-2019

Kementrian Kesehatan RI. Penderita Asma di Indonesia. Indonesia; 2019.

Kementerian Kesehatan RI. Hasil Penelitian Riset Kesehatan Dasar. Indonesia; 2017.

Global Strategy For Asthma Management and Prevention. Global Initiative for Asthma; 2021.

Global Initiative For Asthma. Diagnosis of Diseases of Chronic Airflow Limitation: Asthma COPD and Asthma - COPD Overlap Syndrome. 2014.

B S, L CP. Pathophysiology Of Asthma [Internet]. StatPearls Publishing; 2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK551579/

Padila. Asuhan Keperawatan Penyakit Dalam. Yogyakarta: Nuha Medika; 2015.

S S, I A, AW S, B S, AF S. Buku Ajar Ilmu Penyakit Dalam. I. Jakarta: Interna Publishing; 2014. 478-488 p.

Reviona D, Munir SM, Azrin M. Penilain Derajat Asma dengan Menggunakan Asthma Control Test (ACT) pada Pasien Asma yang Mengikuti Senam Asma di Pekanbaru. Jom. 2014;1(2):1-13.

Perhimpunan Dokter Paru Indonesia (PDPI). Pedoman Diagnosis & Penatalaksanaan Asma Di Indonesia. Jakarta; 2019.

Rai I bagus N, Artana IB. Astma Meeting: Comprehenssive Approach Of Asthma. Denpasar; 2016.

Ardiyansah S. Aplikasi senam asma terhadap peningkatan fungsi paru pada TN. dan Sdr. I dengan asma bronkial di Wilayah Kabupaten Magelang. Universitas Muhammdiyah Magelang; 2020.

Downloads

Additional Files

Published

2022-07-26

Issue

Averrous, Vol.8 : No.1 (Mei 2022)

Section

Articles

License

Authors retain copyright and grant the journal right of first publication and this work is licensed under a Creative Commons Attribution-ShareAlike 4.0 that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.

All articles in this journal may be disseminated by listing valid sources and the title of the article should not be omitted. The content of the article is liable to the author.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.

In the dissemination of articles, the author must declare the AVERROUS: Jurnal Kedokteran dan Kesehatan Malikussaleh Journal as the first party to publish the article.